Sabine Schmid

3.4k total citations · 2 hit papers
62 papers, 2.0k citations indexed

About

Sabine Schmid is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sabine Schmid has authored 62 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Sabine Schmid's work include Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (13 papers) and Occupational and environmental lung diseases (8 papers). Sabine Schmid is often cited by papers focused on Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (13 papers) and Occupational and environmental lung diseases (8 papers). Sabine Schmid collaborates with scholars based in Switzerland, Canada and United States. Sabine Schmid's co-authors include Martin Früh, Wolfram Jochum, Lukas Flatz, Stefan Diem, Arnoud J. Templeton, Diana Born, Aurelius Omlin, Karl Heinimann, Harald Frick and C. Herrmann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Sabine Schmid

59 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

2017 690 citations Stefan Diem, Sabine Schmid et al. Lung Cancer profile →
Multiple primary tumours: challenges and approaches, a review

2017 342 citations Sabine Schmid, Aurelius Omlin et al. ESMO Open profile →

Peers

Countries citing papers authored by Sabine Schmid

Since Specialization

Citations

This map shows the geographic impact of Sabine Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Schmid more than expected).

Fields of papers citing papers by Sabine Schmid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Schmid. The network helps show where Sabine Schmid may publish in the future.

Co-authorship network of co-authors of Sabine Schmid

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Schmid. A scholar is included among the top collaborators of Sabine Schmid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Schmid. Sabine Schmid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment 2024 ·JTO Clinical and Research Reports ·Sabine Schmid, (unknown), (unknown), (unknown), Sacha I. Rothschild, Laura Boos, (unknown), (unknown), Christian Britschgi, Yannis Metaxas, Michael Mark, Patrizia Froesch, Wolf-Dieter Janthur, (unknown), Christine Waibel, (unknown), Martin Früh, Laetitia Mauti	2
2	Complete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer 2023 ·SHILAP Revista de lepidopterología ·(unknown), Simon Haefliger, Ferdinando Cerciello, Tobias Grob, Sabine Schmid	1
3	C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer 2022 ·Journal for ImmunoTherapy of Cancer ·Niklas Klümper, (unknown), Fiamma Berner, (unknown), (unknown), Annkristin Heine, Franz Bauernfeind, Jörg Ellinger, Peter Brossart, Stefan Diem, Sabine Schmid, Markus Joerger, M. Frueh, Manuel Ritter, Michael Hölzel, Lukas Flatz, Tobias Bald	53
4	iRECIST and atypical patterns of response to immuno-oncology drugs 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown), Sabine Schmid, Sally C. M. Lau, Lesley Seymour, Pierre-Olivier Gaudreau, Janice J.N. Li, Penelope Ann Bradbury, Emiliano Calvo	24
5	Sotorasib Shows Intracranial Activity in Patients with <b><i>KRAS G12C-</i></b>Mutated Adenocarcinoma of the Lung and Untreated Active Brain Metastases 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Martin Früh, Sabine Schmid	13
6	Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study 2022 ·ESMO Open ·Michael Mark, Sylvie Rusakiewicz, Martin Früh, Stefanie Hayoz, Federica Grosso, Miklos Pless, Paolo Andrea Zucali, Giovanni Luca Ceresoli, Antonio Maconi, Martina Schneider, Patrizia Froesch, (unknown), Fabrizio Benedetti, Julien Dagher, Lana E. Kandalaft, Roger von Moos, (unknown), Sabine Schmid, Yannis Metaxas	5
7	Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer 2022 ·Clinical Lung Cancer ·Sabine Schmid, Sierra Cheng, (unknown), Miguel García-Pardo, (unknown), Katrina Hueniken, (unknown), (unknown), Devalben Patel, (unknown), (unknown), M. Catherine Brown, Wei Xu, Patrick M. Moriarty, Frances A. Shepherd, Adrian G. Sacher, Natasha B. Leighl, Penelope A. Bradbury, Geoffrey Liu	14
8	116TiP KEYNOTE-B98: Phase Ib/II study of pembrolizumab plus investigational agents as second-line treatment for anti–PD-1/PD-L1-refractory extensive-stage small cell lung cancer (ES-SCLC) 2021 ·Annals of Oncology ·(unknown), M-J. Ahn, (unknown), Dariusz M. Kowalski, Byoung Chul Cho, Sabine Schmid, Maria Jové, Mo Huang, Bin Zhao, Hazem El‐Osta, Alejandro Navarro	1
9	Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial 2021 ·Lung Cancer ·Patrizia Froesch, Michael Mark, Sacha I. Rothschild, Qiyu Li, Gilles Godar, Corinne Rusterholz, Elisabeth Oppliger Leibundgut, Sabine Schmid, Ilaria Colombo, Yannis Metaxas, David König, Cristiana Sessa, Oliver Gautschi, Martin Früh	14
10	Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib 2020 ·Clinical Lung Cancer ·Sabine Schmid, Erin Stewart, Sebastião N. Martins-Filho, Michael Cabanero, Ao Wang, Hua Bao, Xue Wu, (unknown), Zhuo Chen, Jennifer Law, Penelope A. Bradbury, Frances A. Shepherd, Natasha B. Leighl, Ming‐Sound Tsao, Trevor J. Pugh, Scott V. Bratman, Adrian G. Sacher, Geoffrey Liu	5
11	Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data 2019 ·BMC Cancer ·Sabine Schmid, Dirk Klingbiel, Stefan Aebi, Aron Goldhirsch, Christoph Mamot, Elisabetta Munzone, Franco Nolè, C. Oehlschlegel, Olivia Pagani, Bernhard C. Pestalozzi, Christoph Rochlitz, Beat Thürlimann, Roger von Moos, Patrik Weder, Khalil Zaman, Thomas Ruhstaller	7
12	Prognostic impact of the use of antibiotics in patients with advanced non-small cell lung cancer (NSCLC) receiving PD-(L)1 targeting monoclonal antibodies 2019 ·Annals of Oncology ·(unknown), Sacha I. Rothschild, Laetitia Mauti, Sabine Schmid, (unknown), Alessandra Curioni‐Fontecedro, M. Frueh, Markus Joerger	9
13	Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment 2018 ·Cancer Management and Research ·Stefan Diem, Mirjam Fässler, Omar Hasan Ali, Marco Siano, Rebekka Niederer, Fiamma Berner, (unknown), Christoph Ackermann, Sabine Schmid, Sabine Güsewell, Martin Früh, Lukas Flatz	2
14	Incidence of hypocalcemia in a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab (DN) administered every 4 weeks (q4w) versus every 12 weeks (q12w): SAKK 96/12 (REDUSE) 2018 ·Annals of Oncology ·Roger von Moos, Hanne Hawle, Stefanie Hayoz, Richard Cathomas, Andreas Müller, Sabine Schmid, Olivia Pagani, (unknown), Daniel Rauch, Sandro Anchisi, Thomas Hermanns, Mathias K. Fehr, (unknown), (unknown), Martin Zweifel, (unknown), (unknown), (unknown), Silke Gillessen, Arnoud J. Templeton	4
15	Immune checkpoint inhibitors and small cell lung cancer: what’s new? 2018 ·Journal of Thoracic Disease ·Sabine Schmid, Martin Früh	14
16	The role of radiation therapy in the management of small cell lung cancer 2017 ·Breathe ·Markus Glatzer, Sabine Schmid, (unknown), Martin Früh, Paul Martin Putora	20
17	Management of Children with Travel-related Illness Evaluated in a Pediatric Emergency Room 2015 ·The Pediatric Infectious Disease Journal ·(unknown), Christoph Berger, Georg Staubli, David Nadal, Sabine Schmid, Davidson H. Hamer, Rainer Weber, Patricia Schlagenhauf	9
18	Abiraterone—What Is Wrong With the Adrenal Glands? 2014 ·Clinical Genitourinary Cancer ·Sabine Schmid, Jürgen Fornaro, Christian Rothermundt, Aurelius Omlin, Michael Brändle, Niels J. Rupp, Silke Gillessen	1
19	Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of an Intravascular Sarcoma Metastasis 2013 ·Respiration ·Frank Dusemund, (unknown), (unknown), Christian Rothermundt, (unknown), Sabine Schmid, Martin Brutsche	15
20	Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder 2003 ·The Journal of Clinical Psychiatry ·William A. Hewlett, Sabine Schmid, Ronald M. Salomon	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact